Imaging Center COE

Multiparametric Prostate MRI: Current Status - Fergus Coakley

The current status of Multiparametric Prostate MRI imaging Biographies: Phillip J. Koo Fergus V. Coakley, MD is the Chair of the Department of Diagnostic Radiology in the Oregon Health & Science University School of Medicine. He is a Professor in Residence in the Department of Radiology and Biomedical Imaging in the University of California San Francisco (UCSF) School of Medicine. Dr. Coakley is a...

PSMA PET in Prostate Cancer: Steve Cho

Prostate-specific membrane antigen (PSMA) has received a resurgence of attention as a useful biomarker in the imaging evaluation of prostate cancer with PET. Philip Koo, MD, welcomes Steve Cho, MD to discuss PSMA PET in prostate cancer for the inaugural lecture for the Imaging Center of Excellence on UroToday. Dr. Cho's discusses the number of agents that are being developed in prostate cancer and...

Operationalization of Radium-223 Therapy for Bone Metastases - Eric Rohren

An excerpt from Dr. Eric Rohren's state of the art presentation on Radium-223. This discussion includes the operationalization of Radium-223 at MD Anderson. In addition, a review of different agents available for imaging skeletal metastases with metastatic castration-resistant prostate cancer and a look at patient prognosis and survival data. Biography: Eric Rohren, MD. PhD., a national leader in...

Cristina Nanni on Flucicovine F18 (FACBC) in Prostate Cancer - State of the Art Presentation

Cristina Nanni, MD. a leader in prostate cancer nuclear imaging, presents the data on Flucicovine F18 (FACBC), a new radiopharmaceutical and its application in diagnosisng biochemical replapse in post prostatectomy patients based upon a rising PSA. Dr. Nanni also presents details on its mechanism of action in prostate cancer cells, the current clinical approach and reviews of patient case studies...

Axumin™ (Fluciclovine F 18) Injection for PET Imaging of Recurrent Prostate Cancer - Phillip Koo

In this 5 for 5 Hot Topics, Phillip Koo, MD. presents the clinical background of Axumin™ (Fluciclovine F 18) Injection for PET Imaging of Recurrent Prostate Cancer, the first FDA-approved F18 PET Imaging Agent indicated in for use in patients with suspected recurrent prostate cancer. Dr. Koo discusses its use for men with suspected prostate cancer recurrence based on elevated PSA levels following...

Radiotherapy for Prostate Cancer: Hypofractionation of Radiation - Jason Efstathiou

In this edition of 5 for 5, Dr. Jason Efstathiou discusses the benefits of hypofractionation and the radiobiological potential for therapeutic gain in prostate cancer. Dr. Efstathiou reviews the NRG Oncology RTOG 0415, RTOG 0938 studies and the CHHiP Trial. Results from these trials and other moderate hypofractionation trials lead to conclusions that hypofractionation is safe and effective and has...

Radiopharmaceuticals in Prostate Cancer - Stefano Fanti

Stefano Fanti, MD. presents "RADIOPHARMACEUTICALS IN PROSTATE CANCER" from the NCCN and EAU guidelines to the new tracers this state of the art lecture is followed with a Q & A with E. David Crawford, MD. Stefano Fanti, MD. Director of Specialty School of Nuclear Medicine at University of Bologna Nuclear Medicine, Associate Professor, University of Bologna, Director of Nuclear Medicine Division an...

Radium-223: Nuclear Medicine Perspective - Phillip Koo

Phillip Koo, MD Associate Professor, Radiology - Nuclear Medicine University of Colorado School of Medicine Aurora, Colorado Dr. Koo is the associate professor of radiology, nuclear medicine at the University of Colorado School of Medicine. He is a graduate of Drexel University College of Medicine and is a Fellow at the Brigham and Women's Hospital/Children's Hospital/Harvard Medical School Progra...

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.